Literature DB >> 16985683

Evolving Role of Pro-PSA as a New Serum Marker for the Early Detection of Prostate Cancer.

Masood A Khan, Alan W Partin.   

Abstract

Entities:  

Year:  2002        PMID： 16985683      PMCID： PMC1475992     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  8 in total

Review 1.  Free prostate-specific antigen in serum is becoming more complex.

Authors:  Stephen D Mikolajczyk; Leonard S Marks; Alan W Partin; Harry G Rittenhouse
Journal:  Urology       Date:  2002-06       Impact factor: 2.649

2.  Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.

Authors:  W J Catalona; A W Partin; K M Slawin; M K Brawer; R C Flanigan; A Patel; J P Richie; J B deKernion; P C Walsh; P T Scardino; P H Lange; E N Subong; R E Parson; G H Gasior; K G Loveland; P C Southwick
Journal:  JAMA       Date:  1998-05-20       Impact factor: 56.272

3.  A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum.

Authors:  S D Mikolajczyk; L S Grauer; L S Millar; T M Hill; A Kumar; H G Rittenhouse; R L Wolfert; M S Saedi
Journal:  Urology       Date:  1997-11       Impact factor: 2.649

4.  A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer.

Authors:  S D Mikolajczyk; K M Marker; L S Millar; A Kumar; M S Saedi; J K Payne; C L Evans; C L Gasior; H J Linton; P Carpenter; H G Rittenhouse
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

5.  Identification of precursor forms of free prostate-specific antigen in serum of prostate cancer patients by immunosorption and mass spectrometry.

Authors:  J Peter; C Unverzagt; T N Krogh; O Vorm; W Hoesel
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

6.  A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue.

Authors:  S D Mikolajczyk; L S Millar; T J Wang; H G Rittenhouse; L S Marks; W Song; T M Wheeler; K M Slawin
Journal:  Cancer Res       Date:  2000-02-01       Impact factor: 12.701

7.  Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin.

Authors:  H Lilja; A Christensson; U Dahlén; M T Matikainen; O Nilsson; K Pettersson; T Lövgren
Journal:  Clin Chem       Date:  1991-09       Impact factor: 8.327

8.  A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.

Authors:  U H Stenman; J Leinonen; H Alfthan; S Rannikko; K Tuhkanen; O Alfthan
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.